1 – 45 of 45
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe) (
- 2016
- Carl-Gustaf Bergstrand (1914–2011), former Managing Editor of Acta Paediatrica (
- 2009
- Brain tumours in children. (
- 2008
- Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) (
- Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD (
- Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) (
- N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets. (
- Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease. (
- Asn1421Lys mutation in the glycoprotein Ib binding domain impairs - ristocetin and botrocetin - mediated binding of von Willebrand factor to platelets (
- 2007
- Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination (
- ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura. (
- Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD) (
- Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) (
- Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura (
- 2006
- Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. (
- Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor (
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) (
- Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD (
- 2005
- VWF-cleaving protease (ADAMTS13) in premature infants. (
- 2004
- Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells (
- 2003
- Desmopressin (DDAVP) and factor VIII (
- 2002
- Predictors of deterioration of lung function in cystic fibrosis. (
- Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X). (
- 2001
- Symposium in memory of Professor Inga Marie Nilsson (
- 1997
- von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura (
- Bernard-Soulier syndrome Karlstad : Trp 498-->Stop mutation resulting in a truncated glycoprotein Ib alpha that contains part of the transmembranous domain (
- 1996
- Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura (
- 1992
- Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukemia (
- 1991
- Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome (
- 1990
- Platelet surface-bound IgG and platelet-specific IgG in plasma in childhood thrombocytopenia (
- 1987
- Prenataldiagnostik av hemofili A och B genom chorionvillus-biopsi och DNA-analys. (
- 1986
- Platelet-associated IgG in childhood idiopathic thrombocytopenic purpura : measurements on intact and solubilized platelets and after gammaglobulin treatment (
- 1985
- Polymorphism of normal factor IX detected by mouse monoclonal antibodies (
- 1983
- Suppression of Secondary Antibody Response by Intravenous Immunoglobulin in a Patient with Haemophilia B and Antibodies (
- The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg (
- Detection of factor IX inhibitors by immunoradiometric assay (
- 1982
- Haemophilia A and B--two years experience of genetic counselling and prenatal diagnosis (
- Immunoradiometric assay of inhibitors of antihaemophilic factor A (
- Genetic variants of haemophilia B detected by immunoradiometric assay : implications for prenatal diagnosis (
- 1981
- F VIII:CAg in Haemophilia A. A comparison between IRMA:s using haemophilic and spontaneous antibodies (
- Inheritable molecular variants of moderate and mild hemophilia A (
- 1980
- Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX (
- 1979
- Fanconi's anaemia associated with haemophilia A (
- Measurement of antihaemophilic factor A antigen (VII:CAg) with a solid phase immunoradiometric method based on homologous non-haemophilic antibodies. (
- 1978
- Purification of F.VIII:C by antigen-antibody chromatography (